AQXP Short Information, Aquinox Pharmaceuticals Inc.

Twenty Trading Day Totals
Total Shorted Volume	634,054
Total Actual Volume	4,768,199

Averages
Average Short Volume	31,703
Average Short Percentage	39.86%

Is there a AQXP Short Squeeze or Breakout about to happen?

See the AQXP Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2019-08-09	3.50	3.68	3.84	3.46	513,928	60,730	38.9190
2019-08-08	3.29	3.47	3.6848	3.27	418,852	78,362	48.0787
2019-08-07	2.94	3.28	3.30	2.86	791,138	128,834	33.3497
2019-08-06	2.97	2.92	3.18	2.41	1,358,090	102,556	31.9025
2019-08-05	2.78	2.88	2.97	2.68	75,597	33,553	69.4866
2019-08-02	2.83	2.90	2.9558	2.82	133,716	33,856	67.4785
2019-08-01	2.65	2.86	2.91	2.65	179,441	26,496	58.9180
2019-07-31	2.79	2.67	2.79	2.66	62,767	20,521	83.7900
2019-07-30	2.66	2.72	2.805	2.66	49,223	10,445	43.9087
2019-07-29	2.73	2.61	2.73	2.61	33,134	2,201	13.7752
2019-07-26	2.65	2.73	2.76	2.63	33,791	2,743	26.4335
2019-07-25	2.6601	2.65	2.80	2.60	39,851	5,498	52.4018
2019-07-24	2.74	2.76	2.85	2.63	206,191	41,386	40.5697
2019-07-23	2.45	2.76	2.7668	2.43	496,771	56,820	53.3932
2019-07-22	2.43	2.46	2.50	2.40	33,686	1,410	15.6597
2019-07-19	2.45	2.43	2.47	2.42	56,018	1,898	7.1815
2019-07-18	2.43	2.47	2.50	2.43	73,140	11,329	31.6833
2019-07-17	2.53	2.44	2.53	2.39	44,480	300	2.0578
2019-07-16	2.45	2.51	2.52	2.4427	64,517	6,150	43.8941
2019-07-15	2.40	2.45	2.45	2.40	103,868	8,966	34.3907

Stock Information

Aquinox Pharmaceuticals Inc. Company Name:

AQXP Stock Symbol:

NASDAQ Market:

Get AQXP Alerts

News, Short Squeeze, Breakout and More Instantly...

AQXP - Neoleukin Therapeutics and Aquinox Pharmaceuticals Complete Merger Transaction

Nasdaq Ticker Symbol “NLTX” to be effective Monday, August 12, 2019 SEATTLE, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. (“Neoleukin”), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein...
AQXP - Neoleukin Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference

SEATTLE, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. (“Neoleukin”), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, and Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP),...
AQXP - Aquinox Pharmaceuticals and Neoleukin Therapeutics announce merger agreement

• Combined company capitalized with approximately $65M to develop novel immunotherapies • Sophisticated computational platform enables new class of de novo protein therapeutics • Lead program, NL-201, is a potent IL-2/IL-15 agonist with favorable t...